Anna Kanerva
- Genetics top 10%
- Oncology
- Molecular Biology
- Immunology
- Biotechnology top 10%
- Co-authors
- Akseli HemminkiSuvi ParviainenIulia DiaconuVincenzo CerulloSophie EscutenaireSari PesonenMatteo UgoliniSaila K. Pesonen
- Topics
- Virus-based gene therapy research (9 papers)CAR-T cell therapy research (8 papers)Cancer Research and Treatments (3 papers)
- Cited by
- GeneticsOncologyBiotechnology
In The Last Decade
Anna Kanerva
10 papers receiving 293 citations
Peers
Comparison fields: 5 of 33
- Genetics 229
- Oncology 223
- Molecular Biology 102
- Immunology 96
- Biotechnology 65
Countries citing papers authored by Anna Kanerva
This map shows the geographic impact of Anna Kanerva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kanerva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kanerva more than expected).
Fields of papers citing papers by Anna Kanerva
This network shows the impact of papers produced by Anna Kanerva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kanerva. The network helps show where Anna Kanerva may publish in the future.
Co-authorship network of co-authors of Anna Kanerva
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kanerva. A scholar is included among the top collaborators of Anna Kanerva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kanerva. Anna Kanerva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 30 | |
| 4 | 22 | |
| 5 | 38 | |
| 6 | 12 | |
| 7 | 12 | |
| 8 | 136 | |
| 9 | 21 | |
| 10 | 18 |
About Anna Kanerva
Anna Kanerva is a scholar working on Biotechnology, Genetics and Oncology, having authored 10 papers that have together received 298 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (8 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Genetics (229 citations), Oncology (223 citations) and Biotechnology (65 citations). Anna Kanerva has collaborated with scholars based in Finland, Sweden and Germany. Frequent co-authors include Akseli Hemminki, Suvi Parviainen, Iulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, Sari Pesonen, Matteo Ugolini, Saila K. Pesonen, Aristides G. Eliopoulos and Simona Bramante. Their work appears in journals such as PLoS ONE, Cancer Research and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.